UNSPSC 51302306: Climbazole

This classification denotes an antifungal agent with the molecular formula C15H17ClN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9N42CW7I54, chemically known as 2-butanone, 1-(p-chlorophenoxy)-3,3-dimethyl-1-(1-imidazolyl)- but generally known as climbazole, which bears US NIH Compound Identifier 37907. European Medicines Agency schedules Climbazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06662MIG.

UNSPSC 51302306 Climbazole is a Commodity code for a specific antifungal active ingredient used in personal care and pharmaceutical formulations. State and local governments procure climbazole primarily as a component in medical aid supplies and first aid kits distributed by emergency response departments. The City of Tampa Fire Rescue Department's recent ITB 25-P-00157 for medical aid supplies, posted April 24, 2026, illustrates the practical scope: the city is acquiring a comprehensive range of first aid items including antiseptic sprays, hydrogen peroxide, pain relievers, bandages, and emergency blankets in volumes ranging from 1 to 2,700 units annually across 32 line items. Issuing bodies under this code are primarily municipal departments—fire and rescue services—that maintain emergency response inventory. The procurement vehicle is typically an ITB with one-year initial awards and renewal options; evaluation centers on product quality, vendor responsibility, and compliance with local ordinances and set-aside programs.

The City of Tampa represents the clearest recent activity under this code. The ITB 25-P-00157 carries a total department budget of $100,000 with a one-year initial term and two optional one-year renewals. The city has designated specific set-aside provisions for City-certified Small Local Business Enterprises (SLBEs) and Underutilized Woman and Minority Owned Business Enterprises (U-WMBEs), offering a 5% bid discount capped at $10,000 for SLBEs and $20,000 for U-WMBEs. All medications must maintain a minimum nine-month expiration date from acceptance. The bid opening was scheduled for April 9, 2025, with electronic submission through the OpenGov eProcurement Portal; bidders must submit a Letter of Intent within ten work days of opening and provide subcontract agreements or purchase orders before engaging certified WMBE/SLBE subcontractors.